Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2025 9.32%
December 31, 2024 50.73%
September 30, 2024 55.39%
June 30, 2024 52.55%
March 31, 2024 52.50%
December 31, 2023 19.92%
September 30, 2023 47.40%
June 30, 2023 -7.18%
March 31, 2023 42.65%
December 31, 2022 40.68%
September 30, 2022 49.49%
June 30, 2022 43.48%
March 31, 2022 45.87%
December 31, 2021 60.42%
September 30, 2021 68.51%
June 30, 2021 67.83%
March 31, 2021 55.61%
December 31, 2020 54.10%
September 30, 2020 45.60%
June 30, 2020 42.67%
March 31, 2020 41.38%
December 31, 2019 41.34%
September 30, 2019 30.82%
June 30, 2019 43.17%
March 31, 2019 55.56%
Date Value
December 31, 2018 51.76%
September 30, 2018 24.56%
June 30, 2018 7.55%
March 31, 2018 -24.12%
December 31, 2017 29.32%
September 30, 2017 -43.18%
June 30, 2017 17.30%
March 31, 2017 22.94%
December 31, 2016 64.94%
September 30, 2016 3.37%
June 30, 2016 2.37%
March 31, 2016 -37.09%
December 31, 2015 36.13%
September 30, 2015 -39.41%
June 30, 2015 -18.43%
March 31, 2015 -1.62%
December 31, 2014 60.49%
September 30, 2014 -1.62%
June 30, 2014 5.45%
March 31, 2014 -65.60%
December 31, 2013 36.75%
September 30, 2013 -102.3%
June 30, 2013 -84.21%
March 31, 2013 -85.93%
December 31, 2012 -45.25%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
HealthEquity, Inc. 66.06%
Hims & Hers Health, Inc. 51.16%
Frélii, Inc. --
Genesis Healthcare, Inc. --
Pharmagen, Inc. --